Labelling Solution Offers an Instant Validated Platform for C0VID-19 Clinical Trials

摘要

Prisym ID,a leading provider of data-led label and artwork management solutions today announced its Prisym 360 SaaS clinical trials labelling solution is live with customers and available to those pharmaceutical and trials organisations who need quick entry to clinical label printing.To support the life sciences sector's response to Covid-19,Prisym ID is offering a cloud-based,ready to use version of its clinical trials SaaS labelling platform including a pre-validated pack with industry standard print processes.It is fast to onboard,needs minimal IT input to set up and provides certainty to the market in these uncharted times.